Suhel Parvez
Suhel Parvez publishes mostly in Molecular Biology, Cellular and Molecular Neuroscience and Physiology, on topics such as Neuroscience and Neuropharmacology Research, Alzheimer's disease research and treatments and Mitochondrial Function and Pathology.
- World rank
- #257,907 of 7,710,434 ranked researchers
- Rank in India
- #2,772 of 280,097
- Works
- 338
- Citations
- 12k
- Citations per work
- 34.1
What does Suhel Parvez research?
Suhel Parvez's work is mostly in Biochemistry, Genetics and Molecular Biology (17%), Neuroscience (11%), Medicine (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else20159.6%
- Life Sciences9528.2%
- Biochemistry, Genetics and Molecular Biology5817.2%
- Neuroscience3711.0%
- Health Sciences267.8%
- Medicine267.8%
- Physical Sciences154.4%
- Environmental Science154.4%
- 1Molecular Biology17% of their works
- 2Cellular and Molecular Neuroscience8% of their works
- 3Physiology4% of their works
- 4Health, Toxicology and Mutagenesis4% of their works
- 5Neurology3% of their works
- 6Neurology3% of their works
Research topics
- Neuroscience and Neuropharmacology Research
- Alzheimer's disease research and treatments
- Mitochondrial Function and Pathology
- Tryptophan and brain disorders
- Cholinesterase and Neurodegenerative Diseases
- Neuroinflammation and Neurodegeneration Mechanisms
- Environmental Toxicology and Ecotoxicology
- Chemotherapy-induced organ toxicity mitigation
Which keywords describe Suhel Parvez's research?
The keywords of their largest research topics: Oxidative Stress, Neuroinflammation, Neurodegeneration, Neurotransmission, Synaptic Plasticity, Neurodegenerative Diseases, Mitochondrial Dysfunction and Cytokines.
- Nephrotoxicity
- Biomarkers
- Astrocytes
- Acetylcholinesterase
- Depression
- Mitochondria
- Amyloid Hypothesis
- Cytokines
- Neurodegenerative Diseases
- Neurotransmission
- Neuroinflammation
- Oxidative Stress
- Neurodegeneration
- Synaptic Plasticity
- Mitochondrial Dysfunction
- Microglia
- Tau Pathology
- Reactive Oxygen Species
- Tryptophan Metabolism
- Cholinesterase Inhibitors
- Bioaccumulation
- Cisplatin
- Synaptic Pruning
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Oxidative Stress995 topics
- Neuroinflammation633 topics
- Neurodegeneration432 topics
- Neurotransmission431 topic
- Synaptic Plasticity431 topic
- Neurodegenerative Diseases402 topics
- Mitochondrial Dysfunction362 topics
- Cytokines352 topics
- Microglia352 topics
- Amyloid Hypothesis281 topic
- Tau Pathology281 topic
- Mitochondria211 topic
- Reactive Oxygen Species211 topic
- Depression201 topic
- Tryptophan Metabolism201 topic
- Acetylcholinesterase191 topic
- Cholinesterase Inhibitors191 topic
- Astrocytes151 topic
- Bioaccumulation151 topic
- Biomarkers151 topic
- Cisplatin151 topic
- Nephrotoxicity151 topic
- Synaptic Pruning151 topic
Where does Suhel Parvez work?
Suhel Parvez's main affiliation in the publication record is Jamia Hamdard, India.
How many publications and citations does Suhel Parvez have?
OpenAlex counts 338 works and 11,541 citations for Suhel Parvez, an h-index of 59, ranking #257,907 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Suhel Parvez. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.